サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1291493

エピネフリン自動注射器市場：用量別、用途別、エンドユーザー別、地域別2023-2028

Epinephrine Autoinjector Market by Dosage, Application, End User, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
エピネフリン自動注射器市場：用量別、用途別、エンドユーザー別、地域別2023-2028
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

エピネフリン自動注射器の世界市場規模は、2022年に22億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に9.40%の成長率（CAGR）を示し、2028年までに34億米ドルに達すると予測しています。アレルギーを持つ人の増加、医薬品の自己投与ニーズの高まり、スマートエピネフリン自動注射器の発売などが、市場を牽引する重要な要因のひとつです。

エピネフリン自動注射器は、刺されたり、虫に刺されたり、薬物によって引き起こされる重度のアレルギー反応を治療するために、1回分のエピネフリンを簡単に投与するために用いられる医療機器です。個人の太ももの筋肉に薬を投与するように設計されており、血管を収縮させ、気道を拡張させることでアレルギー反応の症状を最小限に抑えるように働きます。小型で携帯しやすく、個人またはヘルスケア専門家が投与することができます。現在、大手メーカー各社は、エピネフリン自動注射器に複数回分の薬剤をセットし、アレルギー反応の程度に応じて投与量を調整し、治療効果を高めることができるようにしたものを発売しています。また、個人が緊急時に使用しやすいように、音声や視覚による説明も取り入れています。

エピネフリン自動注射器の市場動向：

アレルギーやアレルギー反応を持つ人の増加、自己投与薬のニーズの高まりは、世界中でエピネフリン自動注射器の需要を促進する主要な要因の一つとなっています。さらに、関節炎、喘息、がん、慢性閉塞性肺疾患（COPD）の急増と、アレルギー反応を起こしやすい高齢化社会の到来が、市場にプラスの影響を与えています。さらに、大衆の間で食物アレルギーの発生率が増加していることも、市場の成長を後押ししています。これとは別に、多くの国の行政機関が、学校やその他の公共の場でのエピネフリン自動注射器の使用を促進する取り組みを行っています。これは、エピネフリン自動注射器に関する認知度の向上と相まって、市場の成長に寄与しています。さらに、主要企業は、Bluetooth接続、センサー、機械学習などの先進技術を統合したスマートエピネフリン自動注射器を導入し、より便利で使い勝手が良く、効果的なものにしています。また、主要プレイヤーは、スマートフォンやその他のデバイスに接続できるモバイル用途を発売しており、遠隔監視、使用量や有効期限の追跡、患者が推奨用量を超えないようにすることが可能です。これらの進歩は、アレルギー反応の可能性を予測し、治療のための個別提案を提供するのにも役立ちます。これに加えて、エピネフリン自動注射器に自動体外式除細動器（AED）を組み込んで包括的な緊急対応システムを提供することで、市場の明るい見通しが生まれています。

本レポートで回答した主な質問

  • エピネフリン自動注射器の世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界のエピネフリン自動注射器市場における促進要因、抑制要因、および機会は何か？
  • 各 促進要因、抑制要因、機会が世界のエピネフリン自動注射器市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的なエピネフリン自動注射器市場はどの国か？
  • 投与量に基づく市場内訳は？
  • エピネフリン自動注射器市場で最も魅力的な用法用量はどれですか？
  • 用途に基づく市場の内訳は？
  • エピネフリン自動注射器市場において最も魅力的な用途はどれか？
  • エンドユーザー別の市場内訳は？
  • エピネフリン自動注射器市場において最も魅力的なエンドユーザーはどこか？
  • 世界のエピネフリン自動注射器市場の競争構造は？
  • 世界のエピネフリン自動注射器市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 範囲と調査手法

  • 研究の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測調査手法論

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な業界動向

第5章 世界のエピネフリン自動注射器市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 用量別の市場内訳

  • 0.15mgエピネフリン自動注射器
    • 市場動向
    • 市場予測
  • 0.3mgエピネフリン自動注射器
    • 市場動向
    • 市場予測
  • 0.5mgエピネフリン自動注射器
    • 市場動向
    • 市場予測

第7章 用途別の市場内訳

  • 6歳未満
    • 市場動向
    • 市場予測
  • 6～12歳
    • 市場動向
    • 市場予測
  • 12年以上
    • 市場動向
    • 市場予測

第8章 エンドユーザーごとの市場内訳

  • 病院
    • 市場動向
    • 市場予測
  • クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東とアフリカ
    • 市場動向
    • 国別市場内訳
    • 市場予測

第10章 促進要因、抑制要因、および機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Adamis Pharmaceuticals Corporation
    • Amneal Pharmaceuticals Inc.
    • Antares Pharma Inc
    • Bausch Health
    • Kaleo Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.

これは企業の一部のリストのみを示しており、完全なリストはレポートに記載されていることに注意してくださいです。

図表

List of Figures

  • Figure 1: Global: Epinephrine Autoinjector Market: Major Drivers and Challenges
  • Figure 2: Global: Epinephrine Autoinjector Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Epinephrine Autoinjector Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Epinephrine Autoinjector Market: Breakup by Dosage (in %), 2022
  • Figure 5: Global: Epinephrine Autoinjector Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Epinephrine Autoinjector Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Epinephrine Autoinjector Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Epinephrine Autoinjector (Under 6 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Epinephrine Autoinjector (Under 6 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Epinephrine Autoinjector (6 to 12 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Epinephrine Autoinjector (6 to 12 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Epinephrine Autoinjector (Over 12 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Epinephrine Autoinjector (Over 12 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Epinephrine Autoinjector (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Epinephrine Autoinjector (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Epinephrine Autoinjector (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Epinephrine Autoinjector (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Epinephrine Autoinjector (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Epinephrine Autoinjector (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Epinephrine Autoinjector Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Epinephrine Autoinjector Industry: Drivers, Restraints, and Opportunities
  • Figure 76: Global: Epinephrine Autoinjector Industry: Value Chain Analysis
  • Figure 77: Global: Epinephrine Autoinjector Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Epinephrine Autoinjector Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Epinephrine Autoinjector Market Forecast: Breakup by Dosage (in Million US$), 2023-2028
  • Table 3: Global: Epinephrine Autoinjector Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Epinephrine Autoinjector Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Epinephrine Autoinjector Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Epinephrine Autoinjector Market: Competitive Structure
  • Table 7: Global: Epinephrine Autoinjector Market: Key Players
目次
Product Code: SR112023A7369

Market Overview:

The global epinephrine autoinjector market size reached US$ 2.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.40% during 2023-2028. The increasing number of individuals with allergies, rising need for self-administrating medicines, and the launch of smart epinephrine autoinjector represent some of the key factors driving the market.

Epinephrine autoinjector is a medical device used to administer single dose epinephrine easily for treating severe allergic reactions caused by stings, bug bites, or drugs. It is designed to deliver the medication into the thigh muscle of an individual and works by constricting blood vessels and dilating the airways to minimize the symptoms of an allergic reaction. It is small and easy to carry and can be administered by individuals or healthcare professionals. At present, leading manufacturers are introducing epinephrine autoinjector with multiple doses of medications and adjustable dosages that enable the user to adjust the dose according to the severity of the allergic reaction and improve the effectiveness of the treatment. They are also incorporating audio and visual instructions to make it easier for individuals to use them in an emergency. 

Epinephrine Autoinjector Market Trends:

The increasing number of individuals with allergies and allergic reactions and the rising need for self-administrating medicines represent one of the major factors driving the demand for epinephrine autoinjectors around the world. Moreover, the surging prevalence of arthritis, asthma, cancer, and chronic obstructive pulmonary disease (COPD) and the growing aging population, which is more prone to develop allergic reactions, is influencing the market positively. In addition, the increasing incidence of food allergies among the masses is bolstering the growth of the market. Apart from this, governing agencies of numerous countries are undertaking initiatives to promote the use of epinephrine autoinjectors in schools and other public spaces. This, coupled with the rising awareness about epinephrine autoinjectors, is contributing to the market growth. Furthermore, key players are introducing smart epinephrine autoinjectors that are integrated with advanced technologies, including Bluetooth connectivity, sensors, and machine learning, to make them more convenient, user friendly, and effective. Leading players are also launching mobile applications that can be connected to smartphones or other devices, allowing remote monitoring, tracking of usage and expiration dates, and ensuring the patient does not exceed the recommended dosage. These advancements can also help predict the likelihood of an allergic reaction and provide personalized recommendations for treatment. This, along with the incorporation of an automated external defibrillator (AED) in epinephrine autoinjectors to offer a comprehensive emergency response system, is creating a positive outlook for the market.  

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global epinephrine autoinjector market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on dosage, application, and end user.

Dosage Insights:

  • 0.15mg Epinephrine Autoinjector
  • 0.3mg Epinephrine Autoinjector
  • 0.5mg Epinephrine Autoinjector

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the dosage. This includes 0.15mg epinephrine autoinjector, 0.3mg epinephrine autoinjector, and 0.5mg epinephrine autoinjector. According to the report, 0.3mg epinephrine autoinjector represented the largest segment.

Application Insights:

  • Under 6 Years
  • 6 to 12 Years
  • Over 12 Years

A detailed breakup and analysis of the epinephrine autoinjector market based on the application has also been provided in the report. This includes under 6 years, 6 to 12 years, and over 12 years. According to the report, 6 to 12 years represented the largest segment.

End User Insights:

  • Hospitals
  • Clinics
  • Others

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the end user. This includes hospitals, clinics, and others. According to the report, hospitals represented the largest segment.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for epinephrine autoinjectors. Some of the factors driving the North America epinephrine autoinjector market included the rising prevalence of allergies, increasing awareness about anaphylaxis, and the availability of cost-effective generic versions of autoinjectors.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global epinephrine autoinjector market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Adamis Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc., Antares Pharma Inc, Bausch Health, Kaleo Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global epinephrine autoinjector market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global epinephrine autoinjector market?
  • What is the impact of each driver, restraint, and opportunity on the global epinephrine autoinjector market?
  • What are the key regional markets?
  • Which countries represent the most attractive epinephrine autoinjector markets?
  • What is the breakup of the market based on the dosage?
  • Which is the most attractive dosage in the epinephrine autoinjector market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the epinephrine autoinjector market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the epinephrine autoinjector market?
  • What is the competitive structure of the global epinephrine autoinjector market?
  • Who are the key players/companies in the global epinephrine autoinjector market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Epinephrine Autoinjector Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Dosage

  • 6.1 0.15mg Epinephrine Autoinjector
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 0.3mg Epinephrine Autoinjector
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 0.5mg Epinephrine Autoinjector
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Under 6 Years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 6 to 12 Years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Over 12 Years
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adamis Pharmaceuticals Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Amneal Pharmaceuticals Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Antares Pharma Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Bausch Health
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Kaleo Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Teva Pharmaceutical Industries Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Viatris Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.